IBUTAMOREN (MK-677)

Ghrelin Receptor Agonist • GH/IGF-1 Axis & Metabolic Research Compound

For Research Use Only

Overview

Ibutamoren (MK-677) is a synthetic, non-peptide growth hormone secretagogue (GHS) developed for research involving the growth hormone/IGF-1 axis, ghrelin signaling, metabolism, body composition, skeletal-muscle physiology, bone biology, and sleep physiology.

MK-677 acts primarily as an agonist of the growth hormone secretagogue receptor (GHS-R1a), commonly known as the ghrelin receptor.

Unlike exogenous growth hormone, MK-677 has been investigated for its ability to stimulate the body’s endogenous pulsatile GH secretion through ghrelin-receptor signaling.

Research Areas

MK-677 has been investigated in research involving:

• Growth hormone secretion
• IGF-1 signaling
• Ghrelin receptor biology
• Pituitary physiology
• GH pulsatility
• Skeletal-muscle physiology
• Lean body mass
• Protein metabolism
• Bone remodeling
• Appetite regulation
• Glucose metabolism
• Insulin sensitivity
• Sleep architecture
• Aging-associated physiology
• Energy homeostasis

Mechanism Being Studied

MK-677 binds to and activates GHS-R1a, the same receptor system activated by the endogenous hormone ghrelin.

A simplified pathway is:

MK-677 → GHS-R1a Activation → Hypothalamic/Pituitary Signaling → GH Secretion → IGF-1

This produces research interest in two interconnected systems:

Ghrelin Signaling

and

Growth Hormone / IGF-1 Signaling

Growth Hormone & IGF-1 Research

Clinical research has demonstrated that MK-677 can increase circulating growth hormone and IGF-1 concentrations.

Researchers have therefore investigated:

MK-677 → GH ↑ → IGF-1 ↑ → Changes in Growth & Metabolic Signaling

Areas studied include:

• Protein turnover
• Nitrogen balance
• Skeletal-muscle physiology
• Body composition
• Bone metabolism
• Recovery physiology
• Age-associated changes in GH secretion

Unlike many research compounds in the Voltis catalog, MK-677 has been evaluated in human clinical studies, although it has not become an FDA-approved therapy.

Skeletal Muscle & Body-Composition Research

The GH/IGF-1 pathway plays an important role in protein metabolism and maintenance of lean tissue.

Human studies of MK-677 have reported increases in fat-free mass under certain experimental conditions.

However, this distinction is important:

Increased fat-free mass does not automatically mean increased functional skeletal muscle or improved strength.

For example, clinical research in older adults reported increased fat-free mass without corresponding improvements in strength or physical function.

For Voltis, that’s much more accurate than marketing MK-677 simply as a “muscle-building compound.”

Appetite & Ghrelin Research

Because MK-677 activates the ghrelin receptor, appetite regulation is another major area of research.

Ghrelin is involved in:

• Hunger signaling
• Meal initiation
• Energy balance
• Gastrointestinal physiology
• Growth-hormone secretion
• Metabolic regulation

Researchers therefore use MK-677 to investigate interactions between:

Ghrelin ↔ Brain ↔ Pituitary ↔ Metabolism

Increased appetite has also been reported during human studies of MK-677.

Sleep Physiology Research

Growth hormone secretion is closely associated with sleep, particularly slow-wave sleep.

MK-677 has therefore been investigated in studies examining:

• Sleep architecture
• REM sleep
• Slow-wave sleep
• Nocturnal GH secretion
• Age-related alterations in sleep physiology

Early human research reported changes in certain sleep parameters, but MK-677 should not be represented as an established treatment for insomnia or sleep disorders.

Glucose & Insulin Research

This deserves its own section because it is one of the most important limitations of MK-677.

GH and ghrelin signaling can influence glucose homeostasis and insulin sensitivity.

Human studies have reported findings including:

• Increased fasting glucose
• Changes in insulin sensitivity
• Altered glucose tolerance

Therefore, MK-677 should not simply be described as a metabolic enhancer.

Its effects on the GH/IGF-1 axis can produce both potentially useful experimental effects and undesirable metabolic changes, depending upon the research model.

Why Researchers Study MK-677

MK-677 provides researchers with a way to investigate the intersection of:

Ghrelin → Pituitary GH → IGF-1 → Metabolism & Tissue Physiology

Research applications span:

• Endocrinology
• Skeletal-muscle biology
• Aging research
• Bone metabolism
• Appetite physiology
• Sleep biology
• Glucose metabolism
• GH/IGF-1 signaling

Its oral activity and ability to stimulate endogenous GH secretion distinguish it from injectable recombinant growth hormone and peptide GHRH/GHRP compounds.

MK-677 vs. SARMs

This is worth stating clearly on the Voltis website:

MK-677 IS NOT A SARM.

Although it is frequently grouped with SARMs in online discussions, MK-677 does not primarily act through the androgen receptor.

It is a:

Ghrelin-Receptor Agonist / Growth-Hormone Secretagogue

This distinction is important for scientifically accurate product classification.

Product Features

✔ Premium Research Grade
✔ High-Purity Ibutamoren (MK-677)
✔ Non-Peptide Research Compound
✔ GHS-R1a/Ghrelin-Receptor Research Compound
✔ Third-Party Tested (COA Available)
✔ Identity & Purity Verification
✔ Batch & Lot Traceability
✔ Secure Professional Packaging
✔ Laboratory Research Only

Common Research Applications

Researchers may investigate MK-677 in laboratory and experimental models involving:

• GH/IGF-1 axis signaling
• Ghrelin-receptor physiology
• Pituitary function
• Skeletal-muscle biology
• Protein metabolism
• Body composition
• Bone physiology
• Appetite signaling
• Sleep architecture
• Glucose metabolism
• Aging-associated endocrine physiology

Important Research Distinction

MK-677 has sometimes been marketed online as a “GH alternative,” “muscle builder,” or SARM.” Those descriptions oversimplify its pharmacology.

MK-677 is an investigational ghrelin-receptor agonist/growth-hormone secretagogue.

Human studies have demonstrated biological activity, including increased GH and IGF-1, but research has also identified potential concerns involving glucose metabolism, insulin sensitivity, appetite, edema/fluid retention, and other GH-related effects.

It is not FDA-approved for bodybuilding, anti-aging, muscle growth, sleep improvement, or general wellness.

Storage

Store according to the product’s batch-specific stability documentation.

Protect material from excessive heat, moisture, and direct sunlight. Use validated laboratory handling and storage procedures appropriate for the specific formulation supplied.

Disclaimer

For Research Use Only.

Ibutamoren (MK-677) is an investigational research compound and is not an FDA-approved therapeutic product.

Human research involving GH/IGF-1 signaling, body composition, bone physiology, sleep or metabolism should not be interpreted as establishing MK-677 as a safe or effective treatment for these purposes.

This Voltis Research Co. product is intended exclusively for laboratory research and analytical purposes.

Not intended for human or veterinary use.

Why Choose Voltis Research Co.

At Voltis Research Co., quality begins with verification. Researchers deserve confidence in the identity, purity and consistency of the compounds used in their work.

Qualifying batches undergo independent third-party analytical testing, with batch-specific Certificates of Analysis available to document identity and purity.

The Voltis Commitment

⚡ Research-Grade Quality
⚡ Independent Third-Party Testing
⚡ Batch-Specific Certificate of Analysis (COA)
⚡ High-Purity Research Compounds
⚡ Rigorous Quality Control
⚡ Secure Professional Packaging
⚡ Transparency, Consistency & Reliability

Powering Discovery Through Quality Research.